Oppenheimer Reiterates Outperform on Salesforce, Raises Price Target to $275

Benzinga Newsdesk www.benzinga.com Positive 78.5%

Neg 0% Neu 0% Pos 78.5%

Oppenheimer analyst Brian Schwartz reiterates Salesforce (NYSE:CRM) with a Outperform and raises the price target from $250 to $275.